User menu

Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms.

Bibliographic reference Ghesquières, Hervé ; Cartron, Guillaume ; Seymour, John Francis ; Delfau-Larue, Marie-Hélène ; Offner, Fritz ; et. al. Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms.. In: Blood, Vol. 120, no.13, p. 2650-7 (2012)
Permanent URL http://hdl.handle.net/2078.1/124001